EFTA Document EFTA01960064

To: Jeffrey Epstein[jeevacationGigmailcom] From: Mark L. Epstein Sent Mon 9/2/2013 1:46:46 PM Subject RE: I also wrote on his Caring Bridge site that since the drug was no longer working on his type of cancer, perhaps he should get another type of cancer. From: Jeffrey Epstein [mailto:jeevacation@gmail.com] Sent: Monday, September 02, 2013 9:37 AM To: Mark Epstein Subject: Fwd: Forwarded message From: Warren Eisenstein Date: Monday, September 2, 2013 Subject: To: Jeffrey Epstein leevacation@smail.com> Tarceva stopped working. Had surgery, they implanted a port above my collar bone, and started me on chemo 2 wks ago. They did a very detailed MRI on my brain, found a 2 mm lesion they're gonna target with the Novalis (pinpoint radiation) next week. Other than that, life is wonderful. Keep on Pushin' Warren On Sep 2, 2013, at 7:52 AM, Jeffrey Epstein <jcevacation@gmail.com> wrote: whats up PROT2 PROT0 The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to jeevacation@smail.com, and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to jeevacation@gmail.com, and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved PROT3 33744 PROT1